BioCentury
ARTICLE | Clinical News

Enbrel etanercept recombinant p75 TNF receptor regulatory update

December 11, 2000 8:00 AM UTC

Canada granted marketing approval for Enbrel as monotherapy or in combination with methotrexate to treat moderate to severe active rheumatoid arthritis (RA) in adults who have not responded to a cours...